EP2981263
CABOZANTINIB DOSAGE FORM AND USE IN THE TREATMENT OF CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.4.2014EP published:
29.6.2022EP application number:
14724909.8
EPO information:
European Patent Register
Max expiry date:
3.4.2034
Title in English:
CABOZANTINIB DOSAGE FORM AND USE IN THE TREATMENT OF CANCERLanguage of the patent:
English
Timeline
Today
4.4.2014EP application
29.6.2022EP Publication
Owner
Name:
Exelixis, Inc.Address:
1851 Harbor Bay Parkway, Alameda, CA 94502, US
Inventor
Name:
WEITZMAN, AaronAddress:
Los Altos Hills, CA 94022, US
Priority
Number:
201361808511 PDate:
4.4.2013Country:
US
Classification
Categories:
A61K 9/20, A61K 31/47, A61K 31/194, A61P 35/00